Ovarian Neoplasms

275 clinical trials · Condition

Record	Firm	Date
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy (NCT00653952)	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	1997-05-01
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers (NCT00178802)	The University of Texas Health Science Center, Houston	1996-06-01
Outcomes of Education and Counseling for BRCA1 Testing (NCT00001468)	National Human Genome Research Institute (NHGRI)	1995-03-01
A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin (NCT00001427)	National Cancer Institute (NCI)	1995-01-01
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers (NCT00579163)	Memorial Sloan Kettering Cancer Center	1994-12-01
KOrean Borderline Ovarian Tumor (KOBOT) Registry (NCT02803970)	Kangbuk Samsung Hospital	1994-12-01
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients (NCT00001272)	National Cancer Institute (NCI)	1991-09-01
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors (NCT00080041)	Pharmacyclics LLC.
Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer (NCT00051584)	Seagen Inc.

Every clearance here is in the API, with alerts when new ones post.